The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia

<div>Comparison of MP-MRI parameters and APOE-ε4 gene carrier rate between the two groups. A, Comparison of white matter volume (WMV) between the two groups; B, comparison of white matter hyperintensity (WMH) between the two groups; C, comparison of lacunar infarction (LI) between the two groups; D, comparison of Fazekas scores between the two groups, E, the proportion of cerebral atrophy between the two groups; F, the proportion of APOE-ε4 gene carriage between the two groups.</div>

Contrast Media & Molecular Imaging

fig1

Figure 1

Figure 1: The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia

Figure 1 | The Value of Brain Structural Magnetic Resonance Imaging Combined with APOE--ε4 Genotype in Early Diagnosis and Disease Progression of Senile Vascular Cognitive Impairment No Dementia 